期刊文献+

不同病区和标本来源金黄色葡萄球菌感染的耐药性监测 被引量:5

ANALYSIS ON THE DRUG RESISTANCE OF S.AUREUS FROM DIFFERENT WARDS AND SPECIMENS
暂未订购
导出
摘要 目的:了解不同病区和标本中金黄色葡萄球菌的感染情况及其耐药性变化特别是ORSA的耐药情况。方法:应用MicroScanAutoScan-4专用PC12鉴定板检测210例金黄色葡萄球菌对18种的抗生素的敏感程度,根据仪器专家系统自动分析病原菌对抗生素的MIC浓度和β内酰胺酶阳性结果。结果:所有金黄色葡萄球菌菌株β内酰胺酶阳性,OR-SA菌株以白带最高(85·7%)、其次为精液(76·4%)、尿液(55·0%),伤口分泌物(31·2%)和脓液(5·3%)最低,门诊(标本主要为白带、精液等)、一般住院病人、ICU中ORSA菌株分离率分别为79·6、41·9、25·0%;ORSA菌株对氨苄西林、青霉素G耐药率99·2%,苯唑西林敏感金黄色葡萄球菌(OSSA)对氨苄西林、青霉素G耐药率也超过83·0%;ORSA菌株对诺氟沙星、环丙沙星、红霉素、克林霉素、庆大霉素等多种抗生素的耐药性高于OSSA菌株(P<0·001),并有耐万古霉素菌株的出现;不同病区来源的金黄色葡萄球菌对环丙沙星、红霉素、诺氟沙星、四环素、苯唑西林耐药率高低出现门诊、一般住院病人、ICU依次递减的现象(P<0·05);来自精液、痰液标本的金黄色葡萄球菌对环丙沙星、庆大霉素、苯唑西林的耐药率和白带标本中金黄色葡萄球菌对苯唑西林的耐药率明显高于脓液(P<0·05)。结论:来自社区感染金黄色葡萄球菌高ORSA分离率与标本来源有关,不同标本之间抗生素的敏感性存在差异性,ORSA与OSSA对抗生素耐药性不同。 Objective: To explore the isolation condilion and the drug resistance feature of S. aureus from different wards and specimens, especially the isolation condition of Oxacillin- resistant S. aureus (ORSA) strain. Methods: Bacteria isolated from 2004 to 2005 were identified by Micro - Scan AutoScan - 4. and the determination of bacterial antibiotic susecptibility were performed by the instrument expert system. Results: 210 strains of S. aureus were isolated, all the strains are producing β- lactams. As for different wards, the isolation rate of ORSA strain is 79.6% (outpatient wards), 41.9% (common inpatient wards), 25.0% (ICU) respectivdy, and the resistance rate of Erythomycin, Tetracyline, Gentamicin, clindamycin, Ciprofloxacin, Oxacillin are diminished sequentially among the outpatient wards, the common inpatient wards and ICU (P 〈 0. 001 ). As for different specimens, the isolation rate of MRSA strain is 85.7% (vaginal excretion), 76.4% (seminal fluid), 55.0% (urine), 31.2% (wound secretion), 5.3% (abscess) respectively. In the strains from seminal fluid and sputum, the resistance rate of , Gentamicin, Ciprofloxacin, Oxalillin is apparently higher than that from abscess. Conclusion: The drug resistance of S. aureus differ among wards and specimens, the high isolation rate of ORSA strain from community acquired infection is relevant to the type of the specimens. The surveillance of the drug resistance feature of S. aureus from different wards and specimens will well serve the clinic for reasonable and effective utilization of antibiotics.
出处 《现代预防医学》 CAS 北大核心 2006年第10期1946-1949,共4页 Modern Preventive Medicine
关键词 苯唑西林耐药金黄色葡萄球菌 抗生素 耐药性 社区感染 Oxacillin- resistant S. aureus antibiotic drug resistance community acquired infection
  • 相关文献

参考文献12

  • 1赵先颖,徐元宏,江晓平.医院感染葡萄球菌菌种变迁与耐药性近况[J].中国微生态学杂志,2003,15(1):40-41. 被引量:40
  • 2钟国权,李介华.检测耐甲氧西林葡萄球菌及其耐药性分析[J].现代临床医学生物工程学杂志,1999,5(1):39-40. 被引量:2
  • 3Performance Standards for Antimicrobial Susceptibility Terting;Ninth Informational Supplement,M100-S9[S].NCCLS,1999,18:40.
  • 4Gales AC,Andrade SS,Sader HS,et al.Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals:report from the SENTRY antimicrobial surveillance program[J].J Chemother,2004,16 (4):323-328
  • 5Landman D,Bratu S,Flores C,et al.Molecular epidemiology of oxacillin-resistant Staphylococcus aureus in Brooklyn,New York[J].EurJ Clin Microbiol Infect Dis,2003,22 (1):58-61.
  • 6马越,陈鸿波,李景云,姚蕾,张力,胡昌勤,金少鸿.1999~2000年北京和湖北地区金黄色葡萄球菌耐药性分析[J].中国临床药理学杂志,2002,18(3):185-187. 被引量:20
  • 7李红玉,吕苏成,林君仪,梁卓智.金黄色葡萄球菌医院感染的耐药性调查[J].中华医院感染学杂志,2002,12(2):150-150. 被引量:20
  • 8Hiramatsu K,Hanaki H,Ino T,et al.Methicillin resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility[J].J Antimicrob Chemother,1997,40:135.
  • 9Wu Ben-quan,Tang Yingchun,Zhang Kouxing,et al.Staphylococcus heterogeneouslyresistat to vancomycin in china and antimicrobial activities to imipenrn and vancomycin in combination against it[J].J ClinMicrobiol,2002,10:1109.
  • 10卢怀民.呋喃妥因替代万古霉素对MRSA治疗的研究进展[J].检验诊断与实验室自动化,2004,10:22-23.

二级参考文献19

  • 1王兰荣,张曙光,李珍大.耐甲氧西林金黄色葡萄球菌药敏试验的分析[J].上海医学检验杂志,1993,8(4):199-200. 被引量:8
  • 2汪复,朱德妹,张婴元.上海部分医院细菌耐药性监测及其临床意义[J].中华传染病杂志,1996,14(3):148-151. 被引量:101
  • 3王正连.124株耐甲氧西林葡萄球菌的药敏分析[J]上海医学检验杂志,1993(04).
  • 4National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing. 10th inform suppl. M2-A7 and M7-A5[]..2000
  • 5Steinberg JP,Clark CC,Hackman BO.Nosocomial and community-acquired Staphylococcus aureus bacteriemias from 1980 to 1993.Impact of intravascular devices and methicillin resistance[].Clinical Infectious Diseases.1996
  • 6EdmondMB,WallaceSE,McClishDK,etal.Nosocomialbloodstream infectionsinUnitedStateshospitals:athree-yearanalysis[].Clinical Infectious Diseases.1999
  • 7Kloos WE,Bannerman TL. In Murray P R,Baron E J,Pfaller M A,et al.Manual of Clinical microbiology, 7th ed.American societyfor microbiology, Washington, D[].C.1999
  • 8Gulbinovic J,Myrback KE,Bytautiene J et al.Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden[].Microbial Drug Resistance.2001
  • 9Robers RB,Chung M,Lencastre HD,et al.Distribution of methicillin-resistant Staphylococcus aureus clones amonghealth care facilities in Connecticut, New jersey, and Pennsylvania[].Microbial Drug Resistance.2000
  • 10Sanches IS,Mato R,Lencastre HD,et al.Patterns of multidrug resistance among methicillin-resistant hospital isolatesof coagulase-positive and coagulase-negative Staphylococci collected in the international multicenter study RESIST in 1997 and 1998[].Microbial Drug Resistance.2000

共引文献78

同被引文献31

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部